Literature DB >> 21251657

TGF-β1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue: implication of decreased ERK signaling.

Zeeshan H Syedain1, Robert T Tranquillo.   

Abstract

Cyclic stretching and growth factors like TGF-β have been used to enhance extracellular matrix (ECM) production by cells in engineered tissue to achieve requisite mechanical properties. In this study, the effects of TGF-β1 were evaluated during long-term cyclic stretching of fibrin-based tubular constructs seeded with neonatal human dermal fibroblasts. Samples were evaluated at 2, 5, and 7 weeks for tensile mechanical properties and ECM deposition. At 2 weeks, +TGF-β1 samples had 101% higher collagen concentration but no difference in ultimate tensile strength (UTS) or modulus compared to -TGF-β1 samples. However, at weeks 5 and 7, -TGF-β1 samples had higher UTS/modulus and collagen concentration, but lower elastin concentration compared to +TGF-β1 samples. The collagen was better organized in -TGF-β1 samples based on picrosirius red staining. Western blot analysis at weeks 5 and 7 showed increased phosphorylation of ERK in -TGF-β1 samples, which correlated with higher collagen deposition. The TGF-β1 effects were further evaluated by western blot for αSMA and SMAD2/3 expression, which were 16-fold and 10-fold higher in +TGF-β1 samples, respectively. The role of TGF-β1 activated p38 in inhibiting phosphorylation of ERK was evaluated by treating samples with SB203580, an inhibitor of p38 activation. SB203580-treated cells showed increased phosphorylation of ERK after 1 hour of stretching and increased collagen production after 1 week of stretching, demonstrating an inhibitory role of activated p38 via TGF-β1 signaling during cyclic stretching. One advantage of TGF-β1 treatment was the 4-fold higher elastin deposition in samples at 7 weeks. Further cyclic stretching experiments were thus conducted with constructs cultured for 5 weeks without TGF-β1 to obtain improved tensile properties followed by TGF-β1 supplementation for 2 weeks to obtain increased elastin content, which correlated with a reduction in loss of pre-stress during preconditioning for tensile testing, indicating functional elastin. This study shows that a sequential stimulus approach - cyclic stretching with delayed TGF-β1 supplementation - can be used to engineer tissue with desirable tensile and elastic properties.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21251657      PMCID: PMC3061833          DOI: 10.1016/j.jbiomech.2010.12.007

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  41 in total

1.  Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38.

Authors:  Umberto Kucich; Joan C Rosenbloom; William R Abrams; Joel Rosenbloom
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

2.  ECM gene expression correlates with in vitro tissue growth and development in fibrin gel remodeled by neonatal smooth muscle cells.

Authors:  J J Ross; R T Tranquillo
Journal:  Matrix Biol       Date:  2003-11       Impact factor: 11.583

3.  Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.

Authors:  Madoka Sato; Daniel Shegogue; Elizabeth A Gore; Edwin A Smith; Paul J McDermott; Maria Trojanowska
Journal:  J Invest Dermatol       Date:  2002-04       Impact factor: 8.551

4.  Activation of fibroblast procollagen alpha 1(I) transcription by mechanical strain is transforming growth factor-beta-dependent and involves increased binding of CCAAT-binding factor (CBF/NF-Y) at the proximal promoter.

Authors:  Gisela E Lindahl; Rachel C Chambers; Jenny Papakrivopoulou; Sally J Dawson; Marianne C Jacobsen; Jill E Bishop; Geoffrey J Laurent
Journal:  J Biol Chem       Date:  2001-12-17       Impact factor: 5.157

5.  Mechanical stretch modulates TGF-beta1 and alpha1(I) collagen expression in fetal human intestinal smooth muscle cells.

Authors:  J A Gutierrez; H A Perr
Journal:  Am J Physiol       Date:  1999-11

6.  Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring.

Authors:  Zeeshan H Syedain; Lee A Meier; Jason W Bjork; Ann Lee; Robert T Tranquillo
Journal:  Biomaterials       Date:  2010-10-08       Impact factor: 12.479

7.  Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents.

Authors:  M R Neidert; E S Lee; T R Oegema; R T Tranquillo
Journal:  Biomaterials       Date:  2002-09       Impact factor: 12.479

8.  Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents.

Authors:  Brett C Isenberg; Robert T Tranquillo
Journal:  Ann Biomed Eng       Date:  2003-09       Impact factor: 3.934

9.  Elastic fiber production in cardiovascular tissue-equivalents.

Authors:  Jennifer L Long; Robert T Tranquillo
Journal:  Matrix Biol       Date:  2003-06       Impact factor: 11.583

10.  Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching.

Authors:  Rachel C Chambers; Patricia Leoni; Naftali Kaminski; Geoffrey J Laurent; Renu A Heller
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

View more
  14 in total

1.  Cell-derived matrices for tissue engineering and regenerative medicine applications.

Authors:  Lindsay E Fitzpatrick; Todd C McDevitt
Journal:  Biomater Sci       Date:  2015-01       Impact factor: 6.843

2.  Tissue-engineered vascular grafts created from human induced pluripotent stem cells.

Authors:  Sumati Sundaram; Jennifer One; Joshua Siewert; Stephan Teodosescu; Liping Zhao; Sashka Dimitrievska; Hong Qian; Angela H Huang; Laura Niklason
Journal:  Stem Cells Transl Med       Date:  2014-11-05       Impact factor: 6.940

3.  TGFβ signaling promotes matrix assembly during mechanosensitive embryonic salivary gland restoration.

Authors:  Sarah B Peters; Deirdre A Nelson; Hae Ryong Kwon; Matthew Koslow; Kara A DeSantis; Melinda Larsen
Journal:  Matrix Biol       Date:  2015-01-31       Impact factor: 11.583

4.  Valve interstitial cell tensional homeostasis directs calcification and extracellular matrix remodeling processes via RhoA signaling.

Authors:  Emily J Farrar; Varsha Pramil; Jennifer M Richards; Christopher Z Mosher; Jonathan T Butcher
Journal:  Biomaterials       Date:  2016-07-29       Impact factor: 12.479

5.  Influence of mechanical stimulation on human dermal fibroblasts derived from different body sites.

Authors:  Ruixia Kuang; Zhiguo Wang; Quanchen Xu; Su Liu; Weidong Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

6.  Tubular heart valves from decellularized engineered tissue.

Authors:  Zeeshan H Syedain; Lee A Meier; Jay M Reimer; Robert T Tranquillo
Journal:  Ann Biomed Eng       Date:  2013-07-30       Impact factor: 3.934

7.  Combating Adaptation to Cyclic Stretching By Prolonging Activation of Extracellular Signal-Regulated Kinase.

Authors:  Justin S Weinbaum; Jillian B Schmidt; Robert T Tranquillo
Journal:  Cell Mol Bioeng       Date:  2013-09       Impact factor: 2.321

8.  Decellularized tissue-engineered heart valve leaflets with recellularization potential.

Authors:  Zeeshan H Syedain; Allison R Bradee; Stefan Kren; Doris A Taylor; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2012-12-10       Impact factor: 3.845

9.  Combinatorial screen of dynamic mechanical stimuli for predictive control of MSC mechano-responsiveness.

Authors:  Haijiao Liu; Jenna F Usprech; Prabu Karthick Parameshwar; Yu Sun; Craig A Simmons
Journal:  Sci Adv       Date:  2021-05-07       Impact factor: 14.136

10.  Matrix production and organization by endothelial colony forming cells in mechanically strained engineered tissue constructs.

Authors:  Nicky de Jonge; Dimitri E P Muylaert; Emanuela S Fioretta; Frank P T Baaijens; Joost O Fledderus; Marianne C Verhaar; Carlijn V C Bouten
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.